Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies

Stopping immunosuppression in a transplant patient with donor-derived malignancy offers the theoretical benefit that reconstitution of the patient’s immune system will allow “rejection” of the malignancy, as the malignancy also originates from allogeneic tissue. However, this option exists with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Amara, Dominic, Wisel, Steven A., Braun, Hillary J., Collisson, Eric A., Friedlander, Terence, Worner, Giulia, Roll, Garret R., Hirose, Ryutaro, Stock, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Pancreas and Islet Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725258/
https://www.ncbi.nlm.nih.gov/pubmed/33324741
http://dx.doi.org/10.1097/TXD.0000000000001090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725258/
https://www.ncbi.nlm.nih.gov/pubmed/33324741
http://dx.doi.org/10.1097/TXD.0000000000001090

Ejemplares similares